Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Transplantation for Adult Hematologic Malignancies
NCT00270881Phase 2Completed
- Sponsor
- Keio University
- Start
- Jan 2006
- Primary completion
- Jan 2009
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of umbilical cord blood in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and 1 more, sponsored by Keio University. Primary endpoint: Non-relapse mortality at 1 year. Started Jan 2006; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00270881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270881.